(1)
Rafeifadattis, K. F.; Rizkillah, N.; Aulia, N. N.; Apriani, V.; Sudarjat , H. Empaglifozin In Type 2 Diabetes: From Mechanisms To Clinical Practice – A Comprehensive Review Of Monotherapy, Combinations, And Therapeutic Advantages. JN 2025, 10, 182-195.